Form D · Biotechnology

Algisys, LLC

Mayfield Heights, OH · CIK 0001532845

Offering snapshot reported Aug 14, 2013 · SEC filing

Reported sold: $6.15M
Investors reported: 108
Minimum accepted: $25K
First sale: Sep 20, 2011

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$2,500,000 → $6,153,863
Reported investors65 → 108

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Aug 14, 2013	Amendment	$6,153,863	$3,653,863vs Jan 4, 2012	108	SEC filing
Jan 4, 2012	Amendment	$2,500,000	$1,620,000vs Oct 17, 2011	65	SEC filing
Oct 17, 2011	Initial	$880,000	No comparison	23	SEC filing

Offering details

Securities: Equity
Exemptions: 06
Duration over one year: No
Business combination: No

Sales commissions: $10
Finders' fees: $0
Form D file number: 021-167378

AlgiSys has closed its offering.

10% of all sales.

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
E. Donald Wierenga Jr.	2299425	Centennial Securities Company, LLC · CRD 7763

Source: Form D, filed Aug 14, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Michael Lo Presti	Director
Charles L Roe	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

6610 Hidden Woods Trail
Mayfield Heights, OH, 44143